Elstrom, R L <br/><br/>
Treatment of PTLD with rituximab or chemotherapy.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Mar 2006 
 - 569-76 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1600-6135 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-6143.2005.01211.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymphoproliferative Disorders--drug therapy<br/>Male<br/>Middle Aged<br/>Organ Transplantation--adverse effects<br/>Prednisone--therapeutic use<br/>Retrospective Studies<br/>Rituximab<br/>Survival Rate<br/>Treatment Outcome<br/>Vincristine--therapeutic use